|
Market Closed -
Nasdaq
00:00:00 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 55.06 USD | +1.38% |
|
-0.18% | +13.57% |
| 07-13 | GSK posts encouraging data for bowel cancer treatment Jemperli | AN |
| 06-29 | AnaptysBio, Inc.(NasdaqGS:ANAB) dropped from Russell 3000E Growth Benchmark | CI |
| Market Cap | 1.63B 1.42B 1.34B 1.22B 2.28B 156B 2.29B 16.01B 6.19B 79.35B 6.12B 5.99B 254B | P/E 2026 * |
1,664x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.54B 1.34B 1.27B 1.15B 2.15B 147B 2.16B 15.1B 5.84B 74.86B 5.78B 5.65B 240B | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 7.77x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANAB | Delayed | |
CBOE
| ANAB | Real-time | |
|
Deutsche Boerse AG
| AN6 | Delayed | |
|
Tradegate
| AN6 | Real-time | |
|
Börse Stuttgart
| AN6 | Delayed | |
|
Boerse Muenchen
| AN6 | Real-time |
Last Transcript: AnaptysBio, Inc.
| 1 day | +1.38% | ||
| 1 week | -0.18% | ||
| Current month | -3.45% | ||
| 1 month | -7.76% | ||
| 3 months | -3.01% | ||
| 6 months | -18.18% | ||
| Current year | +13.57% |
| 1 week | 53.22 |  | 55.79 |
| 1 month | 53.22 | | 60.31 |
| Current year | 42 | | 73.3 |
| 1 year | 20.49 | | 73.3 |
| 3 years | 12.21 | | 73.3 |
| 5 years | 12.21 | | 73.3 |
| 10 years | 10 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 46 | 21/03/2022 |
| Director of Finance/CFO | 42 | 11/05/2026 | |
Benjamin Stone
PRN | Corporate Officer/Principal | 35 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 79 | 30/06/2015 |
John Schmid
BRD | Director/Board Member | 63 | 30/06/2015 |
Oleg Nodelman
BRD | Director/Board Member | 49 | 08/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/05/26 | Free | Director | 11,250 | 0.0391% | ||
| 11/05/26 | Free | Chief Financial Officer | 25,765 | 0.0896% | ||
| 27/04/26 | Free | Director | 11,250 | 0.0391% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.38% | -0.18% | +177.94% | +182.36% | 1.63B | |
| +1.76% | +3.88% | +46.85% | +101.12% | 70.89B | |
| +0.39% | +1.90% | +40.69% | +78.21% | 62.32B | |
| +1.14% | -2.59% | -14.37% | +365.92% | 27.07B | |
| +2.95% | +2.34% | +0.52% | -12.74% | 24.78B | |
| +0.62% | +7.73% | +26.85% | -15.89% | 20.59B | |
| -0.83% | -9.47% | +174.16% | +295.44% | 15.52B | |
| +3.01% | +1.85% | +44.63% | +168.18% | 14.49B | |
| +2.43% | +4.24% | -2.05% | +847.59% | 14.14B | |
| +1.00% | +0.24% | +28.02% | +203.83% | 12.35B | |
| Average | +1.34% | +1.45% | +52.33% | +221.40% | 26.38B | |
| Weighted average by Cap. | +1.25% | +2.49% | +37.87% | +163.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 106M 92.08M 87.15M 79.18M 148M 10.13B 149M 1.04B 401M 5.15B 397M 388M 16.47B | 172M 150M 142M 129M 241M 16.49B 242M 1.69B 654M 8.38B 647M 632M 26.83B |
| Net income | 619K 539K 510K 464K 866K 59.29M 871K 6.08M 2.35M 30.13M 2.33M 2.27M 96.46M | 148M 129M 122M 111M 208M 14.21B 209M 1.46B 563M 7.22B 557M 545M 23.11B |
| Net Debt | -92.22M -80.33M -76.02M -69.07M -129M -8.83B -130M -906M -350M -4.49B -346M -339M -14.37B | -293M -255M -242M -219M -410M -28.07B -412M -2.88B -1.11B -14.26B -1.1B -1.08B -45.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | $55.06 | +1.38% | 439,572 |
| 16/09/26 | $54.31 | -0.68% | 394,071 |
| 15/09/26 | $54.68 | +1.05% | 351,771 |
| 14/09/26 | $54.11 | +0.45% | 436,876 |
| 11/09/26 | $53.87 | -2.34% | 336,187 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANAB Stock
Select your edition
All financial news and data tailored to specific country editions
